Details for 2017189925
Up to date per 19.05.2026
Actions
Details for 2017189925
Granted/Registered
European Patent
21.02.2018 A
04.11.2020 B1
30.12.2010
US
201061428699 P
31.03.2011
US
201161470406 P
31.03.2011
US
201161470382 P
11.05.2011
US
201161485104 P
C07K 16/28 20060101AFI20180117BHEP
Owner
Takeda Pharmaceutical Company Limited1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045JP
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
ELIAS, Kathleen Annc/o Takeda California, Inc. 9625 Towne Centre Drive San Diego, CA 92121US
LANDES, Gregoryc/o Takeda California, Inc. 9625 Towne Centre Drive San Diego, CA 92121US
SINGH, Shwetac/o Takeda California, Inc. 9625 Towne Centre Drive San Diego, CA 92121US
KORVER, Wouterc/o Takeda California, Inc. 9625 Towne Centre Drive San Diego, CA 92121US
DRAKE, Andrew Wallingc/o Takeda California, Inc. 9625 Towne Centre Drive San Diego, CA 92121US
HAAK-FRENDSCHO, Maryc/o Takeda California, Inc. 9625 Towne Centre Drive San Diego, CA 92121US
SNELL, Gyorgy Palc/o Takeda California, Inc. 9625 Towne Centre Drive San Diego, CA 92121US
BHASKAR, Vinayc/o Takeda California, Inc. 9625 Towne Centre Drive San Diego, CA 92121US
Information about Fees